MedPath

Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria

Not Applicable
Conditions
Pyelonephritis
Asymptomatic Bacteriuria
Interventions
Drug: Antibiotic treatment
Other: No treatment
Registration Number
NCT01771432
Lead Sponsor
Núria Sabé Fernàndez
Brief Summary

Objective: To determine whether antibiotic treatment of asymptomatic bacteriuria in kidney transplant recipients could be useful to prevent pyelonephritis in these patients.

Detailed Description

Design: Randomized prospective study. Setting: University Hospital with an active kidney transplantation program. Patients: Adult kidney transplant recipients. Interventions: Kidney transplant recipients with asymptomatic bacteriuria will be randomly assigned to be treated with antibiotics or to be followed without antibiotic therapy.

Measurements: Urine cultures will be collected weekly during the first month after transplantation, every 2 weeks until three months after transplantation, every month until 6 months after transplantation and every 3 months until 12 months after transplantation. Urine culture will be as well collected if urinary symptoms appeared.

Primary end points: To determine in both groups: the incidence of pyelonephritis.

Secondary end points: To determine outcomes in both groups (renal function, hospitalization, rejection, graft loss, opportunistic infections and mortality) and infection by multiresistant microorganisms.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients who receive a transplant allograft during study period
Exclusion Criteria
  • No acceptation of study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Antibiotic treatmentAntibiotic treatmentKidney transplant recipients with asymptomatic bacteriuria will be treated with antibiotics.
No treatmentNo treatmentKidney transplant recipients with asymptomatic bacteriuria will be followed without antibiotic therapy
Primary Outcome Measures
NameTimeMethod
To determine the incidence of pyelonephritis in both groupsFirst year after kidney transplantation
Secondary Outcome Measures
NameTimeMethod
Renal functionFirst year after kydney transplantation
Need for hospitalizationFirst year after kydney transplantation
Incidence of graft lossFirst year after kidney transplantation
MortalityFirst year after kidney transplantation

Trial Locations

Locations (2)

Hospital Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital Universitari de Bellvitge

🇪🇸

L'Hospitalet de Llobregat, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath